Overview Oral Bioavailability of Bilastine Status: Completed Trial end date: 2010-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the absolute bioavailability of an oral bilastine formulation (test drug) compared to the endovenous administration of an IV bilastine formulation (control drug) in healthy volunteers. Phase: Phase 1 Details Lead Sponsor: Faes Farma, S.A.